Lv44
610 积分 2025-12-16 加入
ICH S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals
1个月前
已完结
Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial
3个月前
已完结
Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low Toxicity
3个月前
已完结
皖公网安备34019202002308
